Stem cell-based photodynamic therapy

12Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We have transfected murine neural stem cells (NSCs) and rat umbilical cord matrix-derived stem cells (RUCMSCs) with a plasmid expressing gaussia luciferase (gLuc). These cells are engineered to secrete the luciferase. We have used gLuc containing supernatant from culturing the NSCs to perform in vitro photodynamic therapy of murine melanoma cells (B16F10), and RUCMSCs to perform in vivo PDT of lung melanomas in C57BL/6 mice. The treatment system was comprised of aminolevulic acid as a prodrug for the synthesis of the photosensitizer protoporphyrin IX, gaussia luciferase, and its' substrate coelenterazine. A significant reduction of the number of live melanoma cells in vitro and a borderline significant retardation of tumour growth in vivo was observed after coelenterazine-mediated PDT. © The Royal Society of Chemistry and Owner Societies.

Cite

CITATION STYLE

APA

Shrestha, T. B., Seo, G. M., Basel, M. T., Kalita, M., Wang, H., Villanueva, D., … Bossmann, S. H. (2012). Stem cell-based photodynamic therapy. Photochemical and Photobiological Sciences, 11(7), 1251–1258. https://doi.org/10.1039/c2pp05417e

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free